Last reviewed · How we verify

local anesthetic cream

Yuzuncu Yil University · FDA-approved active Small molecule

Local anesthetic cream blocks sodium channels in nerve fibers to inhibit pain signal transmission at the site of application.

Local anesthetic cream blocks sodium channels in nerve fibers to inhibit pain signal transmission at the site of application. Used for Topical anesthesia for minor skin procedures, Relief of localized pain and itching.

At a glance

Generic namelocal anesthetic cream
Also known asPlacebo, Marcaine, local anesthetic administered paravertebrally, Chriocaina, Naropina
SponsorYuzuncu Yil University
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaDermatology / Pain Management
PhaseFDA-approved

Mechanism of action

Local anesthetics work by penetrating the skin and mucous membranes to reach nerve endings and axons, where they reversibly block voltage-gated sodium channels. This prevents depolarization and propagation of action potentials, thereby interrupting pain sensation in the localized area without affecting systemic consciousness or motor function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: